Building a Cash-Pay Wellness Menu: GLP-1, TRT, ED & Aesthetics

The cash-pay wellness market has become one of the fastest-growing revenue channels in outpatient healthcare—driven by patients who want results, not referrals, and who are willing to pay out-of-pocket for access to care their insurance won't touch. For med spas, gyms, and wellness clinics, adding GLP-1 weight management, hormone optimization, men's health, and high-margin aesthetics to a single menu creates meaningful per-patient revenue and strong retention. But the clinical complexity of prescription services requires more infrastructure than a smoothie add-on. Here's how to build the menu correctly.

Disclaimer: This article is general information, not legal or medical advice. All prescription services require a valid prescriber-patient relationship and appropriate clinical evaluation. Regulations vary by state. Engage qualified healthcare counsel and licensed clinicians for your situation.

Why Cash-Pay Wellness Is Structurally Attractive

Cash-pay medicine removes the insurance intermediary entirely. No prior authorizations, no claim denials, no 90-day payment cycles. Patients pay at the point of service; margins reflect the actual value of clinical expertise and convenience rather than insurance reimbursement schedules. The demographic paying cash for wellness is also high-intent: they researched their condition, they already want the service, and they're comparing you primarily on trust, experience, and convenience—not price alone.

Retention is the other structural advantage. GLP-1 protocols run months to years. TRT requires ongoing monitoring and prescription renewals. Regular aesthetic treatments follow seasonal and life-event patterns. Each of these creates predictable recurring revenue that purely aesthetic-only practices don't enjoy. Clinics that stack medical wellness on top of aesthetics typically see materially higher revenue per patient per year than those offering aesthetics alone.

Service Line 1: GLP-1 Medical Weight Management

GLP-1 receptor agonists—semaglutide, tirzepatide, and their analogs—have reshaped the medical weight-loss conversation. Patients who previously had no effective pharmacological option beyond stimulants are now achieving clinically meaningful weight reduction with a once-weekly injection. Demand for access to these medications at reputable clinical facilities, rather than through anonymous telehealth-only platforms, is robust and growing.

What the clinical structure requires

GLP-1 medications are FDA-approved prescription drugs. Adding them to your menu requires: a licensed prescriber (physician, NP, or PA depending on your state's scope rules) who conducts an appropriate initial evaluation—history, labs, BMI assessment, contraindication screening—before prescribing. The prescriber must have a supervising physician relationship in place for APPs in supervising-required states. If you dispense medications on-site, pharmacy licensing and storage requirements apply. Compounded semaglutide and tirzepatide products are in a regulatory gray zone; FDA has revised its compounding guidance multiple times since the drug shortage period and the current rules must be verified with your legal and compliance team before you source or offer them.

Program structure that works operationally

• Initial consultation: 30-45 minutes with the prescribing clinician. Lab review, history, goal-setting. Separately billed.
• Medication: Transparently priced per dose or per month, with the prescription sourced from a licensed pharmacy (340B, retail, or accredited compounding if applicable).
• Monitoring: Follow-up visits at 4 and 12 weeks, then quarterly. Lab monitoring at clinically appropriate intervals.
• Adjunct services: Body composition tracking, nutrition coaching (non-clinical staff), and optional aesthetic treatments (skin tightening, etc.) to address body contour changes. This is where your existing aesthetics menu integrates naturally.

Service Line 2: Testosterone Replacement Therapy (TRT)

Testosterone is a Schedule III controlled substance under federal law. That single fact separates TRT from nearly every other cash-pay wellness service on your menu and shapes every operational decision: who can prescribe, how it must be stored, how it must be documented, and what the renewal workflow looks like.

DEA registration and prescribing requirements

To prescribe testosterone, a physician must hold an active DEA registration for Schedule III controlled substances. Nurse practitioners and PAs may have DEA authority in some states, depending on their collaborative agreements and state controlled-substance licensing. Before offering TRT, confirm that your supervising physician holds an active DEA registration and that your facility complies with your state's controlled-substance dispensing and storage requirements—including inventory logs, disposal procedures, and access controls.

What a compliant evaluation looks like

A compliant TRT evaluation includes at minimum: a thorough medical history with symptom assessment (using validated instruments such as the ADAM questionnaire), physical examination, and laboratory evaluation including total testosterone (two separate morning measurements), LH, FSH, complete blood count, PSA (for men over 40), and metabolic panel. Prescribing testosterone without documented clinical indication and appropriate workup creates both medical-legal exposure and regulatory risk. No compliant TRT program can function as an automatic refill service; ongoing monitoring—typically every three to six months—is clinically and legally required.

"Testosterone therapy done correctly is genuinely life-changing for the right patient. Testosterone therapy done carelessly is a DEA audit waiting to happen."

Where TRT fits in a wellness menu

Men presenting for TRT are frequently also candidates for ED evaluation, metabolic health programs, and body composition work (directly relevant to your GLP-1 offering). The average TRT patient engaged in a well-structured program represents significant annual recurring revenue across lab monitoring, follow-up visits, and medication—before any aesthetic service touchpoints.

Service Line 3: Men's Health / ED Treatment

Erectile dysfunction affects a large portion of men over 40, and a meaningful share under 40. PDE5 inhibitors (sildenafil, tadalafil) are not controlled substances, which makes the prescribing workflow simpler than TRT—but "simpler" is not "unregulated." A valid prescriber-patient relationship and appropriate evaluation are still legally required before any prescription is written. Clinics that market ED services in ways that imply automatic or guaranteed prescriptions—without evaluation—are operating outside the legal framework in every state.

Building a compliant men's health consultation

• History: onset, severity, cardiovascular risk factors (nitrate use is an absolute contraindication to PDE5 inhibitors), relationship factors, medication review.
• Physical exam or telehealth equivalent, documented in the medical record.
• Informed consent addressing potential cardiovascular interactions, side-effect profile, and when to seek emergency care.
• Prescription issued by the supervising clinician, with follow-up scheduled.

Men's health programs pair naturally with TRT evaluation (low testosterone is a common contributor to ED) and general metabolic health services, making them an efficient addition to an existing men's wellness offering.

Service Line 4: Aesthetics — The High-Margin Anchor

Injectables (neuromodulators and dermal fillers), laser treatments, and energy-based body contouring remain the highest-volume and highest-margin services in most med spa menus. They also serve as the initial entry point for many patients who later convert to medical wellness programs. A patient who comes in for Botox and leaves having learned about your GLP-1 program is a patient whose annual revenue just multiplied.

Scope and supervision (see also our compliance guide)

Aesthetics services involving prescription drugs or medical devices are subject to the same physician supervision and scope-of-practice requirements as your medical wellness lines. If you've already built a robust med spa compliance structure for your aesthetics menu, extending it to cover medical wellness is largely a matter of adding the right clinical protocols and credentialed prescribers to your existing framework.

Pricing aesthetics for cash-pay profitability

• Neuromodulators: price per unit or per area—per unit is more transparent and defensible.
• Fillers: price per syringe by product tier; avoid deep discounting that implies inferior product sourcing.
• Energy devices: package pricing (series of treatments) increases commitment and average transaction size.
• Memberships: monthly plans that credit toward services reduce churn and smooth revenue. Structure them as service credits, not prepaid prescription drug bundles, to stay on the right side of fee-splitting rules.

Menu Architecture: Bundling Without Breaking the Rules

The intuitive move is to create simple monthly membership tiers ("Silver / Gold / Platinum") where patients pay one flat fee and receive a bundle of services. There's nothing wrong with membership models per se, but several specific bundling patterns create legal risk:

• Never bundle prescription drug cost into a flat fee in ways that obscure the prescribing relationship. The prescriber must be compensated for the clinical evaluation, not for the prescription itself.
• Avoid per-script fees to clinical staff. Any arrangement where clinicians are compensated based on the number of prescriptions written—even indirectly—raises anti-kickback concerns.
• Keep lab and monitoring fees transparent. Patients must understand what they're paying for at each stage. Hidden fees that surface at renewal create both refund requests and regulatory attention.

The cleanest structure: a clearly priced consultation fee covering the clinical evaluation, separately itemized medication fees (at your actual cost plus a transparent markup), and service fees for procedures. Membership discounts can apply to the service fee tier without touching the clinical fee structure.

The Clinical Infrastructure Layer

Everything described in this article requires a licensed prescriber working within a compliant physician supervision structure. That means a physician-owned professional entity in CPOM states, documented supervision agreements, standing orders for services the supervising physician isn't performing directly, and a medical director who is actively engaged—not just a name on a wall. See our Med Spa Compliance Checklist for the full picture of what that structure entails.

MDside's physician network provides this clinical layer for partner facilities: licensed physicians, credentialed prescribers, compliant PC structures, and protocol frameworks for each service line. The goal is to let you focus on patient experience and business growth while the clinical governance is handled by a structure built for it. If you want to understand whether your current setup is designed for the menu you want to offer, a discovery call is the right starting point.

State Variation: What Changes Depending on Where You Operate

Scope of practice for NPs and PAs varies dramatically. Some states allow NPs to prescribe controlled substances independently; others require physician oversight for every Schedule III prescription. Telehealth prescribing rules—relevant if your initial evaluations happen remotely before an in-person visit—are also state-specific and have been in flux since the post-pandemic regulatory period. The Ryan Haight Act imposes federal restrictions on prescribing controlled substances without an in-person evaluation that apply nationwide. Verify that your initial TRT evaluation workflow satisfies both state and federal requirements with your healthcare counsel before launch.